MaryamSadeghi

Maryam Sadeghi

Metaoptima

Bio

Maryam Sadeghi is the CEO and Co-Founder of MetaOptima Technology Inc. Born in Miyaneh, Iran, she completed her undergraduate degree in Computer Hardware Engineering at the Iran University of Science and Technology in Tehran before moving to Canada in 2007, where she pursued her PhD in Computing Science at Simon Fraser University in the Medical Image Analysis lab. In 2012, she co-founded MetaOptima Technology Inc. with Dr. Majid Razmara in Vancouver, Canada, where MoleScope and DermEngine were developed for intelligent dermatology, smart skin imaging, analytics and management. The company was one of 10 that were shortlisted for the 2013 BCIC New Ventures Competition, and won a $40,000 Wavefront Wireless prize package. In 2014, Dr. Sadeghi also won the Venture Prize from Coast Capital Savings. From 2013-2015, Dr. Sadeghi was director of the Digital Health Hub (Innovation Boulevard), where she was actively involved in R&D and commercialization activities. She also worked closely with the Gerontology Research Center (GRC) at SFU on innovative health solutions for senior care and independent living. In 2016, Dr. Sadeghi made the Business In Vancouver’s Forty Under 40 Awards List for her innovative work and successful commercialization of the DermEngine platform and MoleScope dermoscope. Recently, Maryam was appointed as a MITACS Research Council member, was credited as one of BC’s most influential women in BC Business Magazine, and her company was listed as a “Ready To Rocket” business in the area of digital health. Maryam became a Canadian citizen in 2017 and won Canada’s Top 25 Immigrants award in 2019 for her success and leadership in R&D, commercializing Canadian innovation and building a fast-growing, globally successful business. Since its development, MetaOptima has become one of the fastest growing digital health technology companies in Canada, with successful expansion into the US, UK, Italy, Australia, and New Zealand. The company is continuing to extend its reach through expansion into the global market, and empower a greater number of physicians and patients for better care outcomes